Soon, Parkinson's patients suffering debilitating tremors could be cured of their shaking using a non-invasive option, according to a recent study.
The University of Virginia School of Medicine research revealed that an initial test to determine if a scalpel-free form of brain surgery can reduce tremor caused by Parkinson's disease has produced encouraging results. However, further research is warranted.
Twenty-seven participants with tremor-dominant Parkinson's disease were enrolled in the small pilot study led by researcher Jeff Elias and conducted at Swedish Neuroscience Institute in Seattle.
The team randomly assigned 20 to be treated with focused ultrasound waves on their brains, while the others received a fake procedure, to account for any potential placebo effect. (They were later offered the opportunity to have the actual procedure). All had tremor that had resisted medical treatment, and all continued taking their existing Parkinson's medication.
The trial participants who received the focused ultrasound procedure had a 62 percent median improvement in their hand tremor three months later. Those who underwent a sham procedure also improved to a lesser degree, however, suggesting some placebo effect. Additional testing is needed to better establish the effectiveness of focused ultrasound for Parkinson's tremor, the researchers concluded.
The median age of trial participants was 67.8 years, and 26 were male. The most significant side effects reported were mild numbness on one side of the body, which improved, and numbness of the face and finger, which were persistent. Two subjects also experienced partial weakness that recovered or improved during the study. (The procedure has since been modified to mitigate this risk of weakness, the researchers say.)
Focused ultrasound already has been approved by the U.S. Food and Drug Administration for the treatment of essential tremor, the most common movement disorder. The technology works by focusing sound waves inside the body to generate a tiny hot spot, much like a magnifying glass focuses light. By carefully controlling this process, researchers can interrupt faulty brain circuits or destroy unwanted tissue.
The researchers believe that a larger, multicenter study is needed to better define the potential role of focused ultrasound in managing Parkinson's disease.
The study is published the scientific journal JAMA Neurology.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
